Alx Oncology Holdings (ALXO) Treasury Shares (2021 - 2025)
Alx Oncology Holdings recorded quarterly Treasury Shares of $57750.0 in Q4 2025, down 4.94% quarter-over-quarter from $60750.0 in Q3 2025, and down 95.4% year-over-year from $1.3 million in Q4 2024.
Alx Oncology Holdings' Treasury Shares history runs 5 years deep, the most recent figure standing at $57750.0 for Q4 2025.
- In Q4 2025, Treasury Shares fell 95.4% year-over-year to $57750.0; the TTM figure through Dec 2025 stood at $57750.0 (down 95.4% YoY), while the FY2025 annual figure was $57750.0, down 95.4% from the prior year.
- Treasury Shares came in at $57750.0 for Q4 2025 at Alx Oncology Holdings, down from $60750.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2024 to a low of $15075.0 in Q4 2021.
- A 5-year average of $469629.4 and a median of $493562.0 in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares jumped 5341.63% in 2022 and slumped 95.4% in 2025, its largest moves.
- Alx Oncology Holdings' Treasury Shares stood at $15075.0 in 2021, then surged by 5341.63% to $820326.0 in 2022, then increased by 15.77% to $949669.0 in 2023, then surged by 32.28% to $1.3 million in 2024, then plunged by 95.4% to $57750.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $57750.0, $60750.0, and $69750.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,750.00 |
| Dec 31, 2025 | 57,750.00 |
| Sep 30, 2025 | 60,750.00 |
| Sep 30, 2025 | 60,750.00 |
| Jun 30, 2025 | 69,750.00 |
| Jun 30, 2025 | 69,750.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 949,669.00 |
| Dec 31, 2023 | 949,669.00 |
| Dec 31, 2022 | 820,326.00 |
| Dec 31, 2022 | 820,326.00 |
| Sep 30, 2022 | 870,399.00 |
| Sep 30, 2022 | 870,399.00 |
| Jun 30, 2022 | 493,562.00 |
| Jun 30, 2022 | 493,562.00 |
| Mar 31, 2022 | 500,387.00 |
| Mar 31, 2022 | 500,387.00 |
| Dec 31, 2021 | 15,075.00 |
| Dec 31, 2021 | 15,075.00 |